Danny R. Welch - Publications

Pennsylvania State University, State College, PA, United States 
Cell Biology, Molecular Biology, Pathology, Oncology

124 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Welch DR, Hurst DR. Defining the Hallmarks of Metastasis. Cancer Research. PMID 31053634 DOI: 10.1158/0008-5472.Can-19-0458  0.64
2016 Welch DR, Manton CA, Hurst DR. Breast Cancer Metastasis Suppressor 1 (BRMS1): Robust Biological and Pathological Data, But Still Enigmatic Mechanism of Action. Advances in Cancer Research. 132: 111-37. PMID 27613131 DOI: 10.1016/Bs.Acr.2016.05.003  0.64
2016 Welch DR. Tumor Cell Invasion-Not All Barriers Are Created Equal. Cancer Research. 76: 1675-1676. PMID 27197240 DOI: 10.1158/0008-5472.Can-16-0550  0.6
2016 Young ED, Welch DR. Targeting the Untargetable? Nodal Expression in TNBC. Cell Cycle (Georgetown, Tex.). 0. PMID 27027858 DOI: 10.1080/15384101.2016.1166816  0.6
2016 Kurahara H, Bohl C, Natsugoe S, Nishizono Y, Harihar S, Sharma R, Iwakuma T, Welch DR. Suppression of pancreatic cancer growth and metastasis by HMP19 identified through genome-wide shRNA screen. International Journal of Cancer. PMID 27012470 DOI: 10.1002/Ijc.30110  0.6
2015 Welch DR, Antalis TM, Burnstein K, Vona-Davis L, Jensen RA, Nakshatri H, Riegel AT, Spitz DR, Watson DK, Weiner GJ. Essential Components of Cancer Education. Cancer Research. PMID 26627010 DOI: 10.1158/0008-5472.Can-15-2077  0.6
2015 Feeley KP, Bray AW, Westbrook DG, Johnson LW, Kesterson RA, Ballinger SW, Welch DR. Mitochondrial Genetics Regulate Breast Cancer Tumorigenicity and Metastatic Potential. Cancer Research. 75: 4429-36. PMID 26471915 DOI: 10.1158/0008-5472.Can-15-0074  0.6
2014 Xiao L, Harihar S, Welch DR, Zhou A. Imaging of epidermal growth factor receptor on single breast cancer cells using surface-enhanced Raman spectroscopy. Analytica Chimica Acta. 843: 73-82. PMID 25150698 DOI: 10.1016/J.Aca.2014.06.036  0.6
2014 Liu W, Vivian CJ, Brinker AE, Hampton KR, Lianidou E, Welch DR. Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 7: 117-31. PMID 24938990 DOI: 10.1007/S12307-014-0148-4  0.6
2014 Khanna C, Fan TM, Gorlick R, Helman LJ, Kleinerman ES, Adamson PC, Houghton PJ, Tap WD, Welch DR, Steeg PS, Merlino G, Sorensen PH, Meltzer P, Kirsch DG, Janeway KA, et al. Toward a drug development path that targets metastatic progression in osteosarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4200-9. PMID 24803583 DOI: 10.1158/1078-0432.Ccr-13-2574  0.6
2014 Balgkouranidou I, Chimonidou M, Milaki G, Tsarouxa EG, Kakolyris S, Welch DR, Georgoulias V, Lianidou ES. Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer. British Journal of Cancer. 110: 2054-62. PMID 24642624 DOI: 10.1038/Bjc.2014.104  0.6
2014 Jones J, Wang H, Karanam B, Theodore S, Dean-Colomb W, Welch DR, Grizzle W, Yates C. Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas. Clinical & Experimental Metastasis. 31: 497-510. PMID 24570268 DOI: 10.1007/S10585-014-9644-7  0.6
2014 Harihar S, Pounds KM, Iwakuma T, Seidah NG, Welch DR. Furin is the major proprotein convertase required for KISS1-to-Kisspeptin processing. Plos One. 9: e84958. PMID 24454770 DOI: 10.1371/Journal.Pone.0084958  0.6
2014 Liu W, Beck BH, Vaidya KS, Nash KT, Feeley KP, Ballinger SW, Pounds KM, Denning WL, Diers AR, Landar A, Dhar A, Iwakuma T, Welch DR. Metastasis suppressor KISS1 seems to reverse the Warburg effect by enhancing mitochondrial biogenesis. Cancer Research. 74: 954-63. PMID 24351292 DOI: 10.1158/0008-5472.Can-13-1183  0.6
2014 Bohl CR, Harihar S, Denning WL, Sharma R, Welch DR. Metastasis suppressors in breast cancers: mechanistic insights and clinical potential. Journal of Molecular Medicine (Berlin, Germany). 92: 13-30. PMID 24311119 DOI: 10.1007/S00109-013-1109-Y  0.6
2014 Khotskaya YB, Beck BH, Hurst DR, Han Z, Xia W, Hung MC, Welch DR. Expression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix. Molecular Carcinogenesis. 53: 1011-26. PMID 24000122 DOI: 10.1002/Mc.22068  0.6
2014 Liu W, Beck B, Vaidya KS, Nash KT, Ballinger SW, Welch DR. Abstract 126: The KISS1 metastasis suppressor appears to integrate glycolysis, mitochondrial biogenesis and metastasis via regulation of a PGC1α pathway Cancer Research. 74: 126-126. DOI: 10.1158/1538-7445.Am2014-126  0.4
2014 Acharyya S, Matrisian L, Welch DR, Massagué J. Invasion and Metastasis The Molecular Basis of Cancer: Fourth Edition. 269-284.e2. DOI: 10.1016/B978-1-4557-4066-6.00018-4  0.6
2013 Fetterman JL, Zelickson BR, Johnson LW, Moellering DR, Westbrook DG, Pompilius M, Sammy MJ, Johnson M, Dunham-Snary KJ, Cao X, Bradley WE, Zhang J, Wei CC, Chacko B, Schurr TG, ... ... Welch DR, et al. Mitochondrial genetic background modulates bioenergetics and susceptibility to acute cardiac volume overload. The Biochemical Journal. 455: 157-67. PMID 23924350 DOI: 10.1042/Bj20130029  0.6
2013 Diers AR, Vayalil PK, Oliva CR, Griguer CE, Darley-Usmar V, Hurst DR, Welch DR, Landar A. Mitochondrial bioenergetics of metastatic breast cancer cells in response to dynamic changes in oxygen tension: effects of HIF-1α. Plos One. 8: e68348. PMID 23840849 DOI: 10.1371/Journal.Pone.0068348  0.6
2013 Welch DR, Hurst DR. Unraveling the 'TGF-β paradox' one metastamir at a time. Breast Cancer Research : Bcr. 15: 305. PMID 23448381 DOI: 10.1186/Bcr3383  0.6
2013 Hurst DR, Xie Y, Thomas JW, Liu J, Edmonds MD, Stewart MD, Welch DR. The C-terminal putative nuclear localization sequence of breast cancer metastasis suppressor 1, BRMS1, is necessary for metastasis suppression. Plos One. 8: e55966. PMID 23390556 DOI: 10.1371/Journal.Pone.0055966  0.6
2013 Agarwal N, Adhikari AS, Iyer SV, Hekmatdoost K, Welch DR, Iwakuma T. MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4. Oncogene. 32: 462-70. PMID 22370640 DOI: 10.1038/Onc.2012.69  0.6
2013 Liu W, Beck BH, Vaidya KS, Nash KT, Diers AR, Feeley KP, Landar A, Ballinger SW, Welch DR. Abstract 3866: The KISS1 metastasis suppressor appears to reverse the Warburg effect by enhancing mitochondria biogenesis. Cancer Research. 73: 3866-3866. DOI: 10.1158/1538-7445.Am2013-3866  0.4
2013 Vayalil PK, Diers AR, Olivia CR, Griguer CE, Darley-Usmar V, Hurst DR, Welch DR, Landar A. Abstract 1864: Mitochondrial bioenergetics of metastatic breast cancer cells in response to decreasing oxygen tension. Cancer Research. 73: 1864-1864. DOI: 10.1158/1538-7445.Am2013-1864  0.64
2012 Winter SF, Lukes L, Walker RC, Welch DR, Hunter KW. Allelic variation and differential expression of the mSIN3A histone deacetylase complex gene Arid4b promote mammary tumor growth and metastasis. Plos Genetics. 8: e1002735. PMID 22693453 DOI: 10.1371/Journal.Pgen.1002735  0.6
2012 Cook LM, Cao X, Dowell AE, Debies MT, Edmonds MD, Beck BH, Kesterson RA, Desmond RA, Frost AR, Hurst DR, Welch DR. Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis. Clinical & Experimental Metastasis. 29: 315-25. PMID 22241150 DOI: 10.1007/S10585-012-9452-X  0.6
2012 Wang H, Jones J, Turner T, He QP, Hardy S, Grizzle WE, Welch DR, Yates C. Clinical and biological significance of KISS1 expression in prostate cancer. The American Journal of Pathology. 180: 1170-8. PMID 22226740 DOI: 10.1016/J.Ajpath.2011.11.020  0.6
2012 Bodenstine TM, Vaidya KS, Ismail A, Beck BH, Diers AR, Edmonds MD, Kirsammer GT, Landar A, Welch DR. Subsets of ATP-sensitive potassium channel (KATP) inhibitors increase gap junctional intercellular communication in metastatic cancer cell lines independent of SUR expression. Febs Letters. 586: 27-31. PMID 22119728 DOI: 10.1016/J.Febslet.2011.11.017  0.6
2012 Ulasov IV, Kaverina NV, Pytel P, Thaci B, Liu F, Hurst DR, Welch DR, Sattar HA, Olopade OI, Baryshnikov AY, Kadagidze ZG, Lesniak MS. Clinical significance of KISS1 protein expression for brain invasion and metastasis. Cancer. 118: 2096-105. PMID 21928364 DOI: 10.1002/Cncr.26525  0.6
2012 Cook LM, Cao X, Dowell AE, Frost AA, Desmond RA, Edmonds MD, Kesterson RA, Hurst DR, Welch DR. Abstract 3416: Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis Cancer Research. 72: 3416-3416. DOI: 10.1158/1538-7445.Am2012-3416  0.64
2011 Subramaniam D, Nicholes ND, Dhar A, Umar S, Awasthi V, Welch DR, Jensen RA, Anant S. 3,5-bis(2,4-difluorobenzylidene)-4-piperidone, a novel compound that affects pancreatic cancer growth and angiogenesis. Molecular Cancer Therapeutics. 10: 2146-56. PMID 21890747 DOI: 10.1158/1535-7163.Mct-11-0399  0.6
2011 Hurst DR, Welch DR. Unraveling the enigmatic complexities of BRMS1-mediated metastasis suppression. Febs Letters. 585: 3185-90. PMID 21827753 DOI: 10.1016/J.Febslet.2011.07.045  0.6
2011 Lee S, Terry D, Hurst DR, Welch DR, Sang QX. Protein Signatures in Human MDA-MB-231 Breast Cancer Cells Indicating a More Invasive Phenotype Following Knockdown of Human Endometase/Matrilysin-2 by siRNA. Journal of Cancer. 2: 165-76. PMID 21475635 DOI: 10.7150/Jca.2.165  0.64
2011 Kwon YJ, Hurst DR, Steg AD, Yuan K, Vaidya KS, Welch DR, Frost AR. Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines. Clinical & Experimental Metastasis. 28: 437-49. PMID 21442356 DOI: 10.1007/S10585-011-9382-Z  0.6
2011 Bodenstine TM, Beck BH, Cao X, Cook LM, Ismail A, Powers SJ, Powers JK, Mastro AM, Welch DR. Pre-osteoblastic MC3T3-E1 cells promote breast cancer growth in bone in a murine xenograft model. Chinese Journal of Cancer. 30: 189-96. PMID 21352696 DOI: 10.5732/Cjc.010.10582  0.64
2011 Hurst DR, Welch DR. Metastasis suppressor genes at the interface between the environment and tumor cell growth. International Review of Cell and Molecular Biology. 286: 107-80. PMID 21199781 DOI: 10.1016/B978-0-12-385859-7.00003-3  0.6
2011 Cook LM, Hurst DR, Welch DR. Metastasis suppressors and the tumor microenvironment. Seminars in Cancer Biology. 21: 113-22. PMID 21168504 DOI: 10.1016/J.Semcancer.2010.12.005  0.6
2011 Welch DR, Beck BH, Feeley KP, Diers AR, Vaidya KS, Nash KT, Bodenstine TM, Thomas JW, Landar A, Ballinger SW. Abstract 965: The KISS1 metastasis suppressor appears to reverse the ‘Warburg Effect’ Cancer Research. 71: 965-965. DOI: 10.1158/1538-7445.Am2011-965  0.4
2011 Ulasov IV, Kaverina N, Thaci B, Pytel P, Sattar H, Cao D, Hurst DR, Welch DR, Olopade OI, Kadagidze ZG, Lesniak MS. Abstract 1439: Clinical significance of KISS1 protein expression in breast cancer metastasis to brain Cancer Research. 71: 1439-1439. DOI: 10.1158/1538-7445.Am2011-1439  0.64
2011 Khotskaya YB, Beck BH, Hurst DR, Hung M, Welch DR. Abstract 1438: Breast cancer metastasis suppressor 1 (BRMS1) suppresses attachment and spreading of breast cancer cells on 2D and 3D extracellular matrix components by altering focal adhesion-associated signaling Cancer Research. 71: 1438-1438. DOI: 10.1158/1538-7445.Am2011-1438  0.64
2011 Stewart MD, Edmonds MD, Powers JK, Hurst DR, Welch DR. Abstract 1437: Coordinate regulation of miR-183-96-182 and miR10b by Breast Cancer Metastasis Suppressor 1 results in a decrease in migration and invasion of metastatic breast cancer cells Cancer Research. 71: 1437-1437. DOI: 10.1158/1538-7445.Am2011-1437  0.64
2010 Bodenstine TM, Vaidya KS, Ismail A, Beck BH, Cook LM, Diers AR, Landar A, Welch DR. Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition. Cancer Research. 70: 10002-11. PMID 21098703 DOI: 10.1158/0008-5472.Can-10-2606  0.6
2010 McNally LR, Welch DR, Beck BH, Stafford LJ, Long JW, Sellers JC, Huang ZQ, Grizzle WE, Stockard CR, Nash KT, Buchsbaum DJ. KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model. Clinical & Experimental Metastasis. 27: 591-600. PMID 20844932 DOI: 10.1007/S10585-010-9349-5  0.6
2010 Diers AR, Dranka BP, Ricart KC, Oh JY, Johnson MS, Zhou F, Pallero MA, Bodenstine TM, Murphy-Ullrich JE, Welch DR, Landar A. Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy. The Biochemical Journal. 430: 69-78. PMID 20536428 DOI: 10.1042/Bj20091193  0.6
2010 Beck BH, Welch DR. The KISS1 metastasis suppressor: a good night kiss for disseminated cancer cells. European Journal of Cancer (Oxford, England : 1990). 46: 1283-9. PMID 20303258 DOI: 10.1016/J.Ejca.2010.02.023  0.4
2010 Bodenstine TM, Beck BH, Welch DR. Abstract 484: Treatment strategy to reverse osteolytic breast cancer metastasis using osteoblasts in a murine xenograft model Cancer Research. 70: 484-484. DOI: 10.1158/1538-7445.Am10-484  0.4
2010 Bodenstine TM, Vaidya KS, Ismail A, Cook LM, Welch DR. Abstract 1057: BRMS1 restoration of gap junctional intercellular communication involves modulation of KATPchannels and downregulation of phosphoinositide 3-kinase (PI3K) Cancer Research. 70: 1057-1057. DOI: 10.1158/1538-7445.Am10-1057  0.6
2009 Richert MM, Welch DR. Metastasis of hormone receptor positive breast cancer. Cancer Treatment and Research. 147: 1-22. PMID 21461826 DOI: 10.1007/978-0-387-09463-2_6  0.6
2009 Hurst DR, Edmonds MD, Welch DR. Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Research. 69: 7495-8. PMID 19773429 DOI: 10.1158/0008-5472.Can-09-2111  0.6
2009 Byon CH, Hardy RW, Ren C, Ponnazhagan S, Welch DR, McDonald JM, Chen Y. Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4. Laboratory Investigation; a Journal of Technical Methods and Pathology. 89: 1221-8. PMID 19752858 DOI: 10.1038/Labinvest.2009.97  0.6
2009 Edmonds MD, Hurst DR, Welch DR. Linking metastasis suppression with metastamiR regulation. Cell Cycle (Georgetown, Tex.). 8: 2673-5. PMID 19690456 DOI: 10.4161/Cc.8.17.9303  0.6
2009 Frolova N, Edmonds MD, Bodenstine TM, Seitz R, Johnson MR, Feng R, Welch DR, Frost AR. A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 30: 148-59. PMID 19609101 DOI: 10.1159/000228908  0.6
2009 Edmonds MD, Hurst DR, Vaidya KS, Stafford LJ, Chen D, Welch DR. Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression. International Journal of Cancer. Journal International Du Cancer. 125: 1778-85. PMID 19585508 DOI: 10.1002/Ijc.24616  0.6
2009 Shin R, Welch DR, Mishra VK, Nash KT, Hurst DR, Rama Krishna N. Nuclear magnetic resonance and circular dichroism study of metastin (Kisspeptin-54) structure in solution. Clinical & Experimental Metastasis. 26: 527-33. PMID 19308666 DOI: 10.1007/S10585-009-9252-0  0.6
2009 Vaidya KS, Sanchez JJ, Kim EL, Welch DR. Expression of the Breast Cancer Metastasis Suppressor 1 (BRMS1) maintains in vitro chemosensitivity of breast cancer cells. Cancer Letters. 281: 100-7. PMID 19307053 DOI: 10.1016/J.Canlet.2009.02.035  0.4
2009 Richert MM, Vaidya KS, Mills CN, Wong D, Korz W, Hurst DR, Welch DR. Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone. Oncology Reports. 21: 761-7. PMID 19212637 DOI: 10.3892/Or_00000282  0.6
2009 Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Research. 69: 1279-83. PMID 19190326 DOI: 10.1158/0008-5472.Can-08-3559  0.6
2009 Silveira AC, Hurst DR, Vaidya KS, Ayer DE, Welch DR. Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells. Cancer Letters. 276: 32-7. PMID 19070953 DOI: 10.1016/J.Canlet.2008.10.024  0.6
2009 Hurst DR, Xie Y, Edmonds MD, Welch DR. Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model. Clinical & Experimental Metastasis. 26: 89-96. PMID 18841483 DOI: 10.1007/S10585-008-9216-9  0.6
2008 Bodenstine TM, Welch DR. Metastasis suppressors and the tumor microenvironment. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 1: 1-11. PMID 19308680 DOI: 10.1007/S12307-008-0001-8  0.4
2008 Welch DR, Cooper CR, Hurst DR, Lynch CC, Martin MD, Vaidya KS, VanSaun MN, Mastro AM. Metastasis Research Society-American Association For Cancer Research Joint Conference on Metastasis. Cancer Research. 68: 9578-82. PMID 19047132 DOI: 10.1158/0008-5472.Can-08-3360  0.6
2008 Gladson CL, Welch DR. New insights into the role of CXCR4 in prostate cancer metastasis. Cancer Biology & Therapy. 7: 1849-51. PMID 18981717 DOI: 10.4161/Cbt.7.11.7218  0.6
2008 Vaidya KS, Harihar S, Phadke PA, Stafford LJ, Hurst DR, Hicks DG, Casey G, DeWald DB, Welch DR. Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling. The Journal of Biological Chemistry. 283: 28354-60. PMID 18664570 DOI: 10.1074/Jbc.M710068200  0.6
2008 Metge BJ, Frost AR, King JA, Dyess DL, Welch DR, Samant RS, Shevde LA. Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer. Clinical & Experimental Metastasis. 25: 753-63. PMID 18566899 DOI: 10.1007/S10585-008-9187-X  0.6
2008 Hedley BD, Welch DR, Allan AL, Al-Katib W, Dales DW, Postenka CO, Casey G, Macdonald IC, Chambers AF. Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1. International Journal of Cancer. Journal International Du Cancer. 123: 526-34. PMID 18470911 DOI: 10.1002/Ijc.23542  0.6
2008 Stafford LJ, Vaidya KS, Welch DR. Metastasis suppressors genes in cancer. The International Journal of Biochemistry & Cell Biology. 40: 874-91. PMID 18280770 DOI: 10.1016/J.Biocel.2007.12.016  0.4
2008 Phadke PA, Vaidya KS, Nash KT, Hurst DR, Welch DR. BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process. The American Journal of Pathology. 172: 809-17. PMID 18276787 DOI: 10.2353/Ajpath.2008.070772  0.6
2008 Hurst DR, Xie Y, Vaidya KS, Mehta A, Moore BP, Accavitti-Loper MA, Samant RS, Saxena R, Silveira AC, Welch DR. Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells. The Journal of Biological Chemistry. 283: 7438-44. PMID 18211900 DOI: 10.1074/Jbc.M709446200  0.6
2008 Kapoor P, Suva LJ, Welch DR, Donahue HJ. Osteoprotegrin and the bone homing and colonization potential of breast cancer cells. Journal of Cellular Biochemistry. 103: 30-41. PMID 17471510 DOI: 10.1002/Jcb.21382  0.6
2007 Hurst DR, Welch DR. A MSC-ing link in metastasis? Nature Medicine. 13: 1289-91. PMID 17987025 DOI: 10.1038/Nm1107-1289  0.6
2007 Champine PJ, Michaelson J, Weimer BC, Welch DR, DeWald DB. Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression. Clinical & Experimental Metastasis. 24: 551-65. PMID 17896182 DOI: 10.1007/S10585-007-9092-8  0.6
2007 Vaidya KS, Welch DR. Metastasis suppressors and their roles in breast carcinoma. Journal of Mammary Gland Biology and Neoplasia. 12: 175-90. PMID 17587154 DOI: 10.1007/S10911-007-9049-1  0.6
2007 Sadlonova A, Mukherjee S, Bowe DB, Gault SR, Dumas NA, Van Tine BA, Frolova N, Page GP, Welch DR, Novak L, Frost AR. Human breast fibroblasts inhibit growth of the MCF10AT xenograft model of proliferative breast disease. The American Journal of Pathology. 170: 1064-76. PMID 17322389 DOI: 10.2353/Ajpath.2007.060031  0.6
2007 Nash KT, Phadke PA, Navenot JM, Hurst DR, Accavitti-Loper MA, Sztul E, Vaidya KS, Frost AR, Kappes JC, Peiper SC, Welch DR. Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy. Journal of the National Cancer Institute. 99: 309-21. PMID 17312308 DOI: 10.1093/Jnci/Djk053  0.6
2006 Hicks DG, Yoder BJ, Short S, Tarr S, Prescott N, Crowe JP, Dawson AE, Budd GT, Sizemore S, Cicek M, Choueiri TK, Tubbs RR, Gaile D, Nowak N, Accavitti-Loper MA, ... ... Welch DR, et al. Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 6702-8. PMID 17121889 DOI: 10.1158/1078-0432.Ccr-06-0635  0.6
2006 Hurst DR, Mehta A, Moore BP, Phadke PA, Meehan WJ, Accavitti MA, Shevde LA, Hopper JE, Xie Y, Welch DR, Samant RS. Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone. Biochemical and Biophysical Research Communications. 348: 1429-35. PMID 16919237 DOI: 10.1016/J.Bbrc.2006.08.005  0.6
2006 Mukherjee S, Frolova N, Sadlonova A, Novak Z, Steg A, Page GP, Welch DR, Lobo-Ruppert SM, Ruppert JM, Johnson MR, Frost AR. Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer. Cancer Biology & Therapy. 5: 674-83. PMID 16855373 DOI: 10.4161/Cbt.5.6.2906  0.6
2006 Shevde LA, Samant RS, Paik JC, Metge BJ, Chambers AF, Casey G, Frost AR, Welch DR. Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435. Clinical & Experimental Metastasis. 23: 123-33. PMID 16830223 DOI: 10.1007/S10585-006-9013-2  0.6
2006 Phadke PA, Mercer RR, Harms JF, Jia Y, Frost AR, Jewell JL, Bussard KM, Nelson S, Moore C, Kappes JC, Gay CV, Mastro AM, Welch DR. Kinetics of metastatic breast cancer cell trafficking in bone. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 1431-40. PMID 16533765 DOI: 10.1158/1078-0432.Ccr-05-1806  0.6
2006 Samant RS, Debies MT, Hurst DR, Moore BP, Shevde LA, Welch DR. Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1). Cancer Letters. 235: 260-5. PMID 15978719 DOI: 10.1016/J.Canlet.2005.04.032  0.6
2005 Richert MM, Phadke PA, Matters G, DiGirolamo DJ, Washington S, Demers LM, Bond JS, Manni A, Welch DR. Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment. Breast Cancer Research : Bcr. 7: R819-27. PMID 16168128 DOI: 10.1186/Bcr1292  0.6
2005 Koblinski JE, Kaplan-Singer BR, VanOsdol SJ, Wu M, Engbring JA, Wang S, Goldsmith CM, Piper JT, Vostal JG, Harms JF, Welch DR, Kleinman HK. Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis. Cancer Research. 65: 7370-7. PMID 16103089 DOI: 10.1158/0008-5472.Can-05-0807  0.48
2005 DeWald DB, Torabinejad J, Samant RS, Johnston D, Erin N, Shope JC, Xie Y, Welch DR. Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells. Cancer Research. 65: 713-7. PMID 15705865  0.6
2005 Sadlonova A, Novak Z, Johnson MR, Bowe DB, Gault SR, Page GP, Thottassery JV, Welch DR, Frost AR. Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture. Breast Cancer Research : Bcr. 7: R46-59. PMID 15642169 DOI: 10.1186/Bcr949  0.6
2004 Kapoor P, Saunders MM, Li Z, Zhou Z, Sheaffer N, Kunze EL, Samant RS, Welch DR, Donahue HJ. Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells. International Journal of Cancer. Journal International Du Cancer. 111: 693-7. PMID 15252837 DOI: 10.1002/Ijc.20318  0.6
2004 Harms JF, Welch DR, Samant RS, Shevde LA, Miele ME, Babu GR, Goldberg SF, Gilman VR, Sosnowski DM, Campo DA, Gay CV, Budgeon LR, Mercer R, Jewell J, Mastro AM, et al. A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis. Clinical & Experimental Metastasis. 21: 119-28. PMID 15168729 DOI: 10.1023/B:Clin.0000024763.69809.64  0.6
2004 Erin N, Boyer PJ, Bonneau RH, Clawson GA, Welch DR. Capsaicin-mediated denervation of sensory neurons promotes mammary tumor metastasis to lung and heart. Anticancer Research. 24: 1003-9. PMID 15161056  0.6
2004 Lugassy C, Kleinman HK, Engbring JA, Welch DR, Harms JF, Rufner R, Ghanem G, Patierno SR, Barnhill RL. Pericyte-like location of GFP-tagged melanoma cells: ex vivo and in vivo studies of extravascular migratory metastasis. The American Journal of Pathology. 164: 1191-8. PMID 15039208 DOI: 10.1016/S0002-9440(10)63207-5  0.48
2004 Mastro AM, Gay CV, Welch DR, Donahue HJ, Jewell J, Mercer R, DiGirolamo D, Chislock EM, Guttridge K. Breast cancer cells induce osteoblast apoptosis: a possible contributor to bone degradation. Journal of Cellular Biochemistry. 91: 265-76. PMID 14743387 DOI: 10.1002/Jcb.10746  0.6
2004 Meehan WJ, Samant RS, Hopper JE, Carrozza MJ, Shevde LA, Workman JL, Eckert KA, Verderame MF, Welch DR. Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. The Journal of Biological Chemistry. 279: 1562-9. PMID 14581478 DOI: 10.1074/Jbc.M307969200  0.6
2003 Welch DR, Harms JF, Mastro AM, Gay CV, Donahue HJ. Breast cancer metastasis to bone: evolving models and research challenges. Journal of Musculoskeletal & Neuronal Interactions. 3: 30-8. PMID 15758363  0.48
2003 Harms JF, Welch DR. MDA-MB-435 human breast carcinoma metastasis to bone. Clinical & Experimental Metastasis. 20: 327-34. PMID 12856720 DOI: 10.1023/A:1024062911144  0.48
2003 Manni A, Washington S, Craig L, Cloud M, Griffith JW, Verderame MF, Texter LJ, Mauger D, Demers LM, Harms JF, Welch DR. Effects of alpha-difluoromethylornithine on local recurrence and pulmonary metastasis from MDA-MB-435 breast cancer xenografts in nude mice. Clinical & Experimental Metastasis. 20: 321-5. PMID 12856719 DOI: 10.1023/A:1024055522067  0.48
2003 Jenkins AL, Lang CM, Budgeon LR, Cladel NM, Reed CA, Welch DR, Christensen ND, Jenkins AJ. Mucosally-derived HPV-40 can infect both human genital foreskin and cutaneous hand skin tissues grafted into athymic mice. Virus Research. 93: 109-14. PMID 12727348 DOI: 10.1016/S0168-1702(03)00071-6  0.6
2003 Meehan WJ, Welch DR. Breast cancer metastasis suppressor 1: update. Clinical & Experimental Metastasis. 20: 45-50. PMID 12650606 DOI: 10.1023/A:1022542519586  0.6
2003 Harms JF, Welch DR, Miele ME. KISS1 metastasis suppression and emergent pathways. Clinical & Experimental Metastasis. 20: 11-8. PMID 12650602 DOI: 10.1023/A:1022530100931  0.48
2002 Harms JF, Budgeon LR, Christensen ND, Welch DR. Maintaining GFP tissue fluorescence through bone decalcification and long-term storage. Biotechniques. 33: 1197-200. PMID 12503297 DOI: 10.2144/02336Bm02  0.6
2002 Park YG, Lukes L, Yang H, Debies MT, Samant RS, Welch DR, Lee M, Hunter KW. Comparative sequence analysis in eight inbred strains of the metastasis modifier QTL candidate gene Brms1. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 13: 289-92. PMID 12115030 DOI: 10.1007/S00335-001-2151-6  0.6
2002 Shevde LA, Samant RS, Goldberg SF, Sikaneta T, Alessandrini A, Donahue HJ, Mauger DT, Welch DR. Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. Experimental Cell Research. 273: 229-39. PMID 11822878 DOI: 10.1006/Excr.2001.5452  0.4
2001 Debies MT, Welch DR. Genetic basis of human breast cancer metastasis. Journal of Mammary Gland Biology and Neoplasia. 6: 441-51. PMID 12013533 DOI: 10.1023/A:1014739131690  0.6
2000 Samant RS, Seraj MJ, Saunders MM, Sakamaki TS, Shevde LA, Harms JF, Leonard TO, Goldberg SF, Budgeon L, Meehan WJ, Winter CR, Christensen ND, Verderame MF, Donahue HJ, Welch DR. Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clinical & Experimental Metastasis. 18: 683-93. PMID 11827072 DOI: 10.1023/A:1013124725690  0.6
2000 Pethiyagoda CL, Welch DR, Fleming TP. Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells. Clinical & Experimental Metastasis. 18: 391-400. PMID 11467771 DOI: 10.1023/A:1010930918055  0.6
2000 Miele ME, Jewett MD, Goldberg SF, Hyatt DL, Morelli C, Gualandi F, Rimessi P, Hicks DJ, Weissman BE, Barbanti-Brodano G, Welch DR. A human melanoma metastasis-suppressor locus maps to 6q16.3-q23 International Journal of Cancer. 86: 524-528. PMID 10797266 DOI: 10.1002/(Sici)1097-0215(20000515)86:4<524::Aid-Ijc13>3.0.Co;2-W  0.6
1999 Goldberg SF, Harms JF, Quon K, Welch DR. Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate. Clinical & Experimental Metastasis. 17: 601-7. PMID 10845559 DOI: 10.1023/A:1006718800891  0.48
1999 Kiley SC, Clark KJ, Duddy SK, Welch DR, Jaken S. Increased protein kinase C delta in mammary tumor cells: relationship to transformtion and metastatic progression. Oncogene. 18: 6748-57. PMID 10597283 DOI: 10.1038/Sj.Onc.1203101  0.6
1999 Meehan WJ, Spencer JP, Rannels DE, Welch DR, Knobbe ET, Ostrander GK. Hydrogen peroxide induces oxidative DNA damage in rat type II pulmonary epithelial cells. Environmental and Molecular Mutagenesis. 33: 273-8. PMID 10398374 DOI: 10.1002/(Sici)1098-2280(1999)33:4<273::Aid-Em3>3.0.Co;2-T  0.6
1998 West A, Vojta PJ, Welch DR, Weissman BE. Chromosome localization and genomic structure of the KiSS-1 metastasis suppressor gene (KISS1) Genomics. 54: 145-148. PMID 9806840 DOI: 10.1006/Geno.1998.5566  0.6
1998 Robertson GP, Furnari FB, Miele ME, Glendening MJ, Welch DR, Fountain JW, Lugo TG, Huang HJ, Cavenee WK. In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma. Proceedings of the National Academy of Sciences of the United States of America. 95: 9418-23. PMID 9689095 DOI: 10.1073/Pnas.95.16.9418  0.6
1998 Dennis JU, Dean NM, Bennett CF, Griffith JW, Lang CM, Welch DR. Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-α Cancer Letters. 128: 65-70. PMID 9652794 DOI: 10.1016/S0304-3835(98)00052-4  0.6
1998 Phillips KK, White AE, Hicks DJ, Welch DR, Barrett JC, Wei LL, Weissman BE. Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the Kai-1 protein. Molecular Carcinogenesis. 21: 111-20. PMID 9496911 DOI: 10.1002/(Sici)1098-2744(199802)21:2<111::Aid-Mc5>3.0.Co;2-Q  0.6
1997 Yang X, Welch DR, Phillips KK, Weissman BE, Wei LL. KAI1, a putative marker for metastatic potential in human breast cancer. Cancer Letters. 119: 149-55. PMID 9570365 DOI: 10.1016/S0304-3835(97)00273-5  0.6
1997 Halloran MM, Haskell CJ, Woods JM, Hosaka S, Koch AE, Wei Q, Guan Y, Cheng L, Radinsky R, Bar-Eli M, Tsan R, Li L, Legerski RJ, Choi SH, Kim CW, ... Welch DR, et al. Subject Index Vol. 65, 1997 Pathobiology. 65: 342-342. DOI: 10.1159/000164146  0.4
1997 Halloran MM, Haskell CJ, Woods JM, Hosaka S, Koch AE, Wei Q, Guan Y, Cheng L, Radinsky R, Bar-Eli M, Tsan R, Li L, Legerski RJ, Choi SH, Kim CW, ... Welch DR, et al. Contents, Vol. 65, 1997 Pathobiology. 65. DOI: 10.1159/000164139  0.4
1996 Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene Journal of the National Cancer Institute. 88: 1731-1737. PMID 8944003 DOI: 10.1093/Jnci/88.23.1731  0.6
1994 Miele ME, Bennett CF, Miller BE, Welch DR. Enhanced metastatic ability of TNF-α-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides Experimental Cell Research. 214: 231-241. PMID 7915992 DOI: 10.1006/Excr.1994.1253  0.6
1992 Harper DE, Welch DR. Isolation, purification, synthesis, and antiinvasive/antimetastatic activity of U-77863 and U-77864 from Streptomyces griseoluteus, strain WS6724. The Journal of Antibiotics. 45: 1827-36. PMID 1490873 DOI: 10.7164/Antibiotics.45.1827  0.6
1992 Hendrix MJ, Seftor EA, Chu YW, Seftor RE, Nagle RB, McDaniel KM, Leong SP, Yohem KH, Leibovitz AM, Meyskens FL. Coexpression of vimentin and keratins by human melanoma tumor cells: correlation with invasive and metastatic potential. Journal of the National Cancer Institute. 84: 165-74. PMID 1371813 DOI: 10.1093/Jnci/84.3.165  0.6
1991 Yohem KH, Clothier JL, Montague SL, Geary RJ, Winters AL, Hendrix MJ, Welch DR. Inhibition of tumor cell invasion by verapamil Pigment Cell Research / Sponsored by the European Society For Pigment Cell Research and the International Pigment Cell Society. 4: 225-233. PMID 1668559 DOI: 10.1111/J.1600-0749.1991.Tb00445.X  0.6
1989 Estrada J, Freeman DL, Aeed PA, Welch DR. Experimental model for locally recurring mammary tumors. Development, morphology, karyotype, growth kinetics, and experimental metastatic potential. Cancer. 63: 1353-62. PMID 2920363 DOI: 10.1002/1097-0142(19890401)63:7<1353::Aid-Cncr2820630721>3.0.Co;2-F  0.6
1987 Welch DR. Biologic considerations for drug targeting in cancer patients Cancer Treatment Reviews. 14: 351-358. PMID 3326669 DOI: 10.1016/0305-7372(87)90029-6  0.6
1986 Welch DR, Nicolson GL. Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to adriamycin, 5-fluoro-2'-deoxyuridine and methotrexate treatment in vitro. Clinical & Experimental Metastasis. 1: 317-25. PMID 6242707 DOI: 10.1007/Bf00121194  0.64
1985 Welch DR, Krizman DB, Nicolson GL. Multiple phenotypic divergence of mammary adenocarcinoma cell clones. I. In vitro and in vivo properties. Clinical & Experimental Metastasis. 2: 333-55. PMID 6543709 DOI: 10.1007/Bf00135172  0.48
1984 Welch DR, Evans DP, Tomasovic SP, Milas L, Nicolson GL. Multiple phenotypic divergence of mammary adenocarcinoma cell clones. - II. Sensitivity to radiation, hyperthermia and FUdR Clinical &Amp; Experimental Metastasis. 2: 357-371. PMID 6242285 DOI: 10.1007/Bf00135173  0.6
Show low-probability matches.